Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,531.00    1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread: 1.00 (0.065%)
Market Cap: £3.22b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

UK Earnings, Trading Statements Calendar - Next 7 Days
10 May 2019

UK Earnings, Trading Statements Calendar - Next 7 Days

Monday 13 MayΒ DignityQ1 ResultsAngling DirectFull Year Year Year Ports HoldingQ1

UK Shareholder Meetings Calendar - Next 7 Days
10 May 2019

UK Shareholder Meetings Calendar - Next 7 Days

Monday 13 MayMidwich GroupAnglo Pacific GroupCentricaTuesday 14 James's

Wednesday broker round-up
10 Apr 2019

Wednesday broker round-up

(Sharecast News) - Glencore: RBC Capital Markets downgrades to sector perform with a target price of 330p.

WINNERS & LOSERS SUMMARY: Ferrexpo Down As It Finds More Discrepancies
19 Mar 2019

WINNERS & LOSERS SUMMARY: Ferrexpo Down As It Finds More Discrepancies

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 4.3...

LONDON MARKET OPEN: Antofagasta, Ocado And Hikma Send FTSE 100 Higher
19 Mar 2019

LONDON MARKET OPEN: Antofagasta, Ocado And Hikma Send FTSE 100 Higher

LONDON (Alliance News) - Stock prices in London opened mixed on Tuesday, with Antofagasta, Ocado and Hikma Pharmaceuticals driving gains in the a

DIRECTOR DEALINGS: Hikma Non-Executive Henderson Buys Shares
15 Mar 2019

DIRECTOR DEALINGS: Hikma Non-Executive Henderson Buys Shares

LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Non-Executive Director Mary Henderson had bought shares worth GBP31,261 in the drugmaker in a ...

Hikma Pharmaceuticals director buys-in after full-year results
14 Mar 2019

Hikma Pharmaceuticals director buys-in after full-year results

(Sharecast News) - One of Hikma Pharmaceuticals's directors picked-up some shares in the company the day after its latest full-year numbers.

Thursday broker round-up
14 Mar 2019

Thursday broker round-up

(Sharecast News) - Savills: Peel Hunt downgrades to hold with a target price of 925p.